Sets conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by the state board of pharmacy.
Plain English Summary
AI-generatedPlain-English Summary
This bill would allow pharmacists in Rhode Island to prescribe medications that help people quit smoking or using other tobacco products — something that currently only doctors and other licensed prescribers can do. Under the bill, pharmacists would first need to complete a specific educational program approved by the Rhode Island State Board of Pharmacy before they could offer this service to patients.
The bill sets out the rules and requirements pharmacists must meet to prescribe these "tobacco cessation drug therapies," which can include medications like nicotine patches, gums, or prescription drugs designed to reduce tobacco cravings. The goal appears to be making it easier for people to access stop-smoking treatments by adding pharmacists — who are widely accessible in communities — as another option for getting these medications without necessarily needing a separate doctor's appointment.
This bill would primarily affect pharmacists, who would gain new prescribing authority if they meet the education requirements, and Rhode Island residents who use tobacco and want help quitting. It could make the process of getting cessation medications faster and more convenient for many people, especially those who may not have easy access to a primary care doctor.
The bill was introduced in the Rhode Island House and referred to the House Health & Human Services Committee. As of early 2026, the committee has recommended holding it for further study, meaning it has not yet advanced toward a full vote.
This summary is AI-generated for informational purposes. Always refer to the official bill text for legal accuracy.
Sponsors
Legislative History
Committee recommended measure be held for further study
Mar 3, 2026Scheduled for hearing and/or consideration (03/03/2026)
Feb 27, 2026Meeting postponed (02/24/2026)
Feb 23, 2026Scheduled for hearing and/or consideration
Feb 19, 2026Introduced, referred to House Health & Human Services
Feb 6, 2026